Striverdi Respimat is a long-acting beta-adrenergic agonist that helps the muscles around the airways in the lungs stay relaxed to prevent symptoms. Its safety and effectiveness was evaluated in 3,104 people diagnosed with COPD.
Striverdi Respimat is distributed by Boehringer Ingelheim Pharmaceuticals.
More articles on quality:
Patient harms up 70% in Massachusetts hospitals
Study: 9 factors associated with SSI after colon procedures
MRSA colonization not limited to nose: Study
